{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:02:14Z","timestamp":1790654534076,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T00:00:00Z","timestamp":1313193600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00213-011-2434-x","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T04:28:17Z","timestamp":1313123297000},"page":"1039-1053","source":"Crossref","is-referenced-by-count":124,"title":["Pharmacology of ayahuasca administered in two repeated doses"],"prefix":"10.1007","volume":"219","author":[{"given":"Rafael G.","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Grasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Bouso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep F.","family":"Nomded\u00e9u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Homs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel J.","family":"Barbanoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Riba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,13]]},"reference":[{"key":"2434_CR1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0022-3565(24)29230-2","volume":"299","author":"VJ Aloyo","year":"2001","unstructured":"Aloyo VJ, Dave KD, Rahman T, Harvey JA (2001) Selective and divergent regulation of cortical 5-HT2A receptors in rabbit. J Pharmacol Exp Ther 299:1066\u20131072","journal-title":"J Pharmacol Exp Ther"},{"key":"2434_CR2","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th ed., text rev.). APA, Washington DC"},{"key":"2434_CR3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s002130050112","volume":"128","author":"IM Anderson","year":"1996","unstructured":"Anderson IM, Deakin JF, Miller HE (1996) The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology (Berl) 128:74\u201382","journal-title":"Psychopharmacology (Berl)"},{"key":"2434_CR4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0706859","volume":"149","author":"MB Assi\u00e9","year":"2006","unstructured":"Assi\u00e9 MB, Lomenech H, Ravailhe V, Faucillon V, Newman-Tancredi A (2006) Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. Br J Pharmacol 149:170\u2013178","journal-title":"Br J Pharmacol"},{"key":"2434_CR5","first-page":"681","volume":"83","author":"M Bellido","year":"1998","unstructured":"Bellido M, Rubiol E, Ubeda J, Estivill C, L\u00f3pez O, Manteiga R, Nomded\u00e9u JF (1998) Rapid and simple immunophenotypic characterization of lymphocytes using a new test. Haematologica 83:681\u2013685","journal-title":"Haematologica"},{"key":"2434_CR6","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/0024-3205(77)90190-4","volume":"20","author":"NS Buckholtz","year":"1977","unstructured":"Buckholtz NS, Boggan WO (1977) Inhibition by \u03b2-carbolines of monoamine uptake into a synaptosomal preparation: structure-activity relationships. Life Sci 20:2093\u20132099","journal-title":"Life Sci"},{"key":"2434_CR7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-8741(98)00168-8","volume":"65","author":"JC Callaway","year":"1999","unstructured":"Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC (1999) Pharmacokinetics of Hoasca alkaloids in healthy humans. J Ethnopharmacol 65:243\u2013256","journal-title":"J Ethnopharmacol"},{"key":"2434_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00422642","volume":"29","author":"JM Cole","year":"1973","unstructured":"Cole JM, Pieper WA (1973) The effects of N,N-dimethyltryptamine on operant behavior in squirrel monkeys. Psychopharmacologia 29:107\u2013112","journal-title":"Psychopharmacologia"},{"key":"2434_CR9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00213-011-2207-6","volume":"215","author":"JP Dougherty","year":"2011","unstructured":"Dougherty JP, Aloyo VJ (2011) Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL\/6 N mice. Psychopharmacology (Berl) 215:581\u2013593","journal-title":"Psychopharmacology (Berl)"},{"key":"2434_CR10","volume-title":"Entrevista Cl\u00ednica Estructurada para los Trastornos del Eje I del DSM-IV: Versi\u00f3n Cl\u00ednica (SCID-VC)","author":"MB First","year":"1999","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JB (1999) Entrevista Cl\u00ednica Estructurada para los Trastornos del Eje I del DSM-IV: Versi\u00f3n Cl\u00ednica (SCID-VC). Masson, Barcelona"},{"key":"2434_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.npp.1300006","volume":"28","author":"N Ghaziuddin","year":"2003","unstructured":"Ghaziuddin N, Welch K, Greden J (2003) Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents. Neuropsychopharmacology 28:133\u2013139","journal-title":"Neuropsychopharmacology"},{"key":"2434_CR12","first-page":"213","volume":"7","author":"JC Gillin","year":"1973","unstructured":"Gillin JC, Cannon E, Magyar R, Schwartz M, Wyatt RJ (1973) Failure of N,N-dimethyltryptamine to evoke tolerance in cats. Biol Psychiatry 7:213\u2013220","journal-title":"Biol Psychiatry"},{"key":"2434_CR13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/ajp.133.2.203","volume":"133","author":"JC Gillin","year":"1976","unstructured":"Gillin JC, Kaplan J, Stillman R, Wyatt RJ (1976) The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine. Am J Psychiatry 133:203\u2013208","journal-title":"Am J Psychiatry"},{"key":"2434_CR14","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/sj.npp.1300711","volume":"30","author":"PJ Gresch","year":"2005","unstructured":"Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E (2005) Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology 30:1693\u20131702","journal-title":"Neuropsychopharmacology"},{"key":"2434_CR15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archneurpsyc.1956.02330290012002","volume":"76","author":"H Isbell","year":"1956","unstructured":"Isbell H, Belleville RE, Fraser WA, Logan CR (1956) Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication. Arch Neurol Psychiatry 76:468\u2013478","journal-title":"Arch Neurol Psychiatry"},{"key":"2434_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-009-1508-5","volume":"205","author":"V Koudas","year":"2009","unstructured":"Koudas V, Nikolaou A, Hourdaki E, Giakoumaki SG, Roussos P, Bitsios P (2009) Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers. Psychopharmacology (Berl) 205:1\u20139","journal-title":"Psychopharmacology (Berl)"},{"key":"2434_CR17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-3565(25)30534-3","volume":"197","author":"B Kovacic","year":"1976","unstructured":"Kovacic B, Domino EF (1976) Tolerance and limited cross-tolerance to the effects of N,N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat. J Pharmacol Exp Ther 197:495\u2013502","journal-title":"J Pharmacol Exp Ther"},{"key":"2434_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0376-8716(94)90075-2","volume":"35","author":"X Lamas","year":"1994","unstructured":"Lamas X, Farr\u00e9 M, Llorente M, Cam\u00ed J (1994) Spanish version of the 49-item short form of the Addiction Research Center Inventory. Drug Alcohol Depend 35:203\u2013209","journal-title":"Drug Alcohol Depend"},{"key":"2434_CR19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0893-133X(98)00106-7","volume":"20","author":"B Lerer","year":"1999","unstructured":"Lerer B, Gelfin Y, Gorfine M, Allolio B, Lesch KP, Newman ME (1999) 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology 20:628\u2013639","journal-title":"Neuropsychopharmacology"},{"key":"2434_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245\u2013258","journal-title":"Clin Pharmacol Ther"},{"key":"2434_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-8741(84)90003-5","volume":"10","author":"DJ McKenna","year":"1984","unstructured":"McKenna DJ, Towers GHN, Abbott F (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and \u03b2-carboline constituents of ayahuasca. J Ethnopharmacol 10:195\u2013223","journal-title":"J Ethnopharmacol"},{"key":"2434_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-002-1177-0","volume":"164","author":"W Pitchot","year":"2002","unstructured":"Pitchot W, Wauthy J, Hansenne M, Pinto E, Fuchs S, Reggers J, Legros JJ, Ansseau M (2002) Hormonal and temperature responses to the 5-HT1A receptor agonist flesinoxan in normal volunteers. Psychopharmacology (Berl) 164:27\u201332","journal-title":"Psychopharmacology (Berl)"},{"key":"2434_CR23","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.1523\/JNEUROSCI.21-21-08378.2001","volume":"21","author":"M Riad","year":"2001","unstructured":"Riad M, Watkins KC, Doucet E, Hamon M, Descarries L (2001) Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci 21:8378\u20138386","journal-title":"J Neurosci"},{"key":"2434_CR24","unstructured":"Riba J (2003) Human pharmacology of ayahuasca. Doctoral dissertation, Universitat Aut\u00f2noma de Barcelona. Available at http:\/\/www.tdx.cesca.es\/TDX-0701104-165104"},{"key":"2434_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002130000606","volume":"154","author":"J Riba","year":"2001","unstructured":"Riba J, Rodriguez-Fornells A, Urbano G, Morte A, Antonijoan R, Monteiro M, Callaway JC, Barbanoj MJ (2001a) Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers. Psychopharmacology (Berl) 154:85\u201395","journal-title":"Psychopharmacology (Berl)"},{"key":"2434_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(00)00175-7","volume":"62","author":"J Riba","year":"2001","unstructured":"Riba J, Rodriguez-Fornells A, Strassman RJ, Barbanoj MJ (2001b) Psychometric assessment of the Hallucinogen Rating Scale. Drug Alcohol Depend 62:215\u2013223","journal-title":"Drug Alcohol Depend"},{"key":"2434_CR27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2125.2002.01609.x","volume":"53","author":"J Riba","year":"2002","unstructured":"Riba J, Anderer P, Morte A, Urbano G, Jane F, Saletu B, Barbanoj MJ (2002) Topographic pharmaco-EEG mapping of the effects of the South American beverage ayahuasca in healthy volunteers. Br J Clin Pharmacol 53:613\u2013628","journal-title":"Br J Clin Pharmacol"},{"key":"2434_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.103.049882","volume":"306","author":"J Riba","year":"2003","unstructured":"Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ (2003) Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther 306:73\u201383","journal-title":"J Pharmacol Exp Ther"},{"key":"2434_CR29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00213-010-2004-7","volume":"212","author":"AG Romano","year":"2010","unstructured":"Romano AG, Quinn JL, Li L, Dave KD, Schindler EA, Aloyo VJ, Harvey JA (2010) Intrahippocampal LSD accelerates learning and desensitizes the 5-HT2A receptor in the rabbit. Psychopharmacology (Berl) 212:441\u2013448","journal-title":"Psychopharmacology (Berl)"},{"key":"2434_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00429362","volume":"4","author":"DE Rosenberg","year":"1963","unstructured":"Rosenberg DE, Isbell H, Miner EJ (1963) Comparison of a placebo, N-dimethyltryptamine and 6-hydroxy-N-dimethyltryptamine in man. Psychopharmacologia 4:39\u201342","journal-title":"Psychopharmacologia"},{"key":"2434_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00413244","volume":"5","author":"DE Rosenberg","year":"1964","unstructured":"Rosenberg DE, Isbell H, Miner EJ, Logan CR (1964) The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia 5:217\u2013227","journal-title":"Psychopharmacologia"},{"key":"2434_CR32","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0022-3565(25)12228-3","volume":"275","author":"BL Roth","year":"1995","unstructured":"Roth BL, Palvimaki EP, Berry S, Khan N, Sachs N, Uluer A, Choudhary MS (1995) 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. J Pharmacol Exp Ther 275:1638\u20131646","journal-title":"J Pharmacol Exp Ther"},{"key":"2434_CR33","unstructured":"Santos RG, Valle M, Bouso JC, Nomded\u00e9u JF, Rodr\u00edguez-Espinosa J, McIlhenny EH, Barker SA, Barbanoj MJ, Riba J (in press) Autonomic, neuroendocrine and immunological effects of ayahuasca. A comparative study with d-amphetamine"},{"key":"2434_CR34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s002130050348","volume":"132","author":"P Sargent","year":"1997","unstructured":"Sargent P, Williamson DJ, Pearson G, Odontiadis J, Cowen PJ (1997) Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity. Psychopharmacology (Berl) 132:296\u2013302","journal-title":"Psychopharmacology (Berl)"},{"key":"2434_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0893-133X(95)00025-9","volume":"13","author":"B Seletti","year":"1995","unstructured":"Seletti B, Benkelfat C, Blier P, Annable L, Gilbert F, de Montigny C (1995) Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology 13:93\u2013104","journal-title":"Neuropsychopharmacology"},{"key":"2434_CR36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0091-3057(98)00110-5","volume":"61","author":"RL Smith","year":"1998","unstructured":"Smith RL, Canton H, Barret RJ, Sanders-Bush E (1998) Agonist properties of N,N-dimethyltryptamine at 5-HT2A and 5-HT2C serotonin receptors. Pharmacol Biochem Behav 61:323\u2013330","journal-title":"Pharmacol Biochem Behav"},{"key":"2434_CR37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s002130051000","volume":"144","author":"RL Smith","year":"1999","unstructured":"Smith RL, Barrett RJ, Sanders-Bush E (1999) Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor. Psychopharmacology (Berl) 144:248\u2013254","journal-title":"Psychopharmacology (Berl)"},{"key":"2434_CR38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1994.03950020009001","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR (1994) Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic and cardiovascular effects. Arch Gen Psychiatry 51:85\u201397","journal-title":"Arch Gen Psychiatry"},{"key":"2434_CR39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose\u2212response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51:98\u2013108","journal-title":"Arch Gen Psychiatry"},{"key":"2434_CR40","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/0006-3223(95)00200-6","volume":"39","author":"RJ Strassman","year":"1996","unstructured":"Strassman RJ, Qualls CR, Berg LM (1996) Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol Psychiatry 39:784\u2013795","journal-title":"Biol Psychiatry"},{"key":"2434_CR41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugpo.2006.11.001","volume":"19","author":"KW Tupper","year":"2008","unstructured":"Tupper KW (2008) The globalization of ayahuasca: harm reduction or benefit maximization? Int J Drug Policy 19:297\u2013303","journal-title":"Int J Drug Policy"},{"key":"2434_CR42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1570-0232(02)00397-5","volume":"779","author":"M Yritia","year":"2002","unstructured":"Yritia M, Riba J, Ortuno J, Ramirez A, Castillo A, Alfaro Y, De la Torre R, Barbanoj MJ (2002) Determination of N,N-dimethyltryptamine and \u03b2-carboline alkaloids in human plasma following oral administration of ayahuasca. J Chromatogr B 779:271\u2013281","journal-title":"J Chromatogr B"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2434-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-011-2434-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2434-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T15:08:13Z","timestamp":1741446493000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-011-2434-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,13]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["2434"],"URL":"https:\/\/doi.org\/10.1007\/s00213-011-2434-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,13]]}}}